metoprolol has been researched along with Hyperlipemia in 9 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"The effects of celiprolol 200 mg or 400 mg once daily on blood pressure (BP), serum lipids, plasma fibrinogen and airways function was compared with the effects of metoprolol 100 mg or 200 mg once daily in 171 patients with mild to moderate hypertension and coexistent hyperlipidaemia in a double-blind, multicentre study lasting 1 year." | 5.08 | Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial. ( Feely, J; Holden, RD; Johnston, GD; Radley, DR; Vyssoulis, G, 1995) |
"Down syndrome is a genetic disorder known to cause many complications with lifelong effects." | 1.51 | Down syndrome, severe psoriasis, and increased risk for cardiovascular events. ( DʼAcunto, K; Sismour, B, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sismour, B | 1 |
DʼAcunto, K | 1 |
Duan, L | 1 |
Ng, A | 1 |
Chen, W | 1 |
Spencer, HT | 1 |
Nguyen, J | 1 |
Shen, AY | 1 |
Lee, MS | 1 |
Iaccarino, G | 1 |
Trimarco, V | 1 |
Lanni, F | 1 |
Cipolletta, E | 1 |
Izzo, R | 1 |
Arcucci, O | 1 |
De Luca, N | 1 |
Di Renzo, G | 1 |
Lynch, T | 1 |
Bielmann, P | 2 |
Leduc, G | 2 |
Davignon, J | 1 |
Johnston, GD | 1 |
Vyssoulis, G | 1 |
Feely, J | 1 |
Holden, RD | 1 |
Radley, DR | 1 |
Pershad, A | 1 |
Kratzer, S | 1 |
Cooper, A | 1 |
Hitzenberger, G | 1 |
2 trials available for metoprolol and Hyperlipemia
Article | Year |
---|---|
Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
Topics: Adult; Aged; Blood Pressure; Celiprolol; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans | 1995 |
Effects of metoprolol and propranolol on lipid metabolism.
Topics: Cholesterol; Double-Blind Method; Humans; Hyperlipidemias; Lipid Metabolism; Metoprolol; Propanolami | 1979 |
7 other studies available for metoprolol and Hyperlipemia
Article | Year |
---|---|
Down syndrome, severe psoriasis, and increased risk for cardiovascular events.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Down Syndrome; Fat | 2019 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Anta | 2005 |
Medication costs as a primary cause of nonadherence in the elderly.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Coronary Disease; Costs and C | 2006 |
[Selective beta blockaders (metoprolol) versus non selective (propranolol): comparative effects on the composition of lipoprotein fractions and on blood pressure].
Topics: Blood Pressure; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Lip | 1980 |
Coronary revascularization and aggressive lipid lowering.
Topics: Aspirin; Atorvastatin; Coronary Stenosis; Heptanoic Acids; Humans; Hyperlipidemias; Hypertension; Hy | 1999 |
The effects of the beta-adrenoceptor blocking agent, celiprolol, on blood lipids.
Topics: Adrenergic beta-Antagonists; Celiprolol; Humans; Hyperlipidemias; Lipoproteins; Metoprolol; Propanol | 1985 |